Primary Job Title CEO Primary Organization Immunochina
Location Beijing, Beijing, China Regions Asia-Pacific (APAC) Gender Male Also Known As Ting He
LinkedIn View on LinkedIn
He Ting graduated from the Department of Biology in Tsinghua University with a Ph.D. degree, with his research interest in cancer immunology and metastasis during his graduate study. In 2015, Ting established ImmunoChina Pharmaceuticals Co. Ltd. and has worked as the CEO since then. ImmunoChina has received several rounds of investment by venture
capitals such as Peter Thiel and Legend Capital, and now it is the leading bio-company focusing on innovative CAR-T therapy in China.
